Identification of degradation products in stressed tablets of Rabeprazole sodium by HPLC-hyphenated techniques

Copyright (c) 2009 John Wiley & Sons, Ltd.

Bibliographische Detailangaben
Veröffentlicht in:Magnetic resonance in chemistry : MRC. - 1985. - 47(2009), 5 vom: 01. Mai, Seite 443-8
1. Verfasser: Vasu Dev, R (VerfasserIn)
Weitere Verfasser: Sai Uday Kiran, G, Venkata Subbaiah, B, Suresh Babu, B, Moses Babu, J, Dubey, P K, Vyas, K
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2009
Zugriff auf das übergeordnete Werk:Magnetic resonance in chemistry : MRC
Schlagworte:Journal Article 2-Pyridinylmethylsulfinylbenzimidazoles Anti-Ulcer Agents Tablets Rabeprazole 32828355LL
LEADER 01000naa a22002652 4500
001 NLM186025149
003 DE-627
005 20231223173518.0
007 cr uuu---uuuuu
008 231223s2009 xx |||||o 00| ||eng c
024 7 |a 10.1002/mrc.2404  |2 doi 
028 5 2 |a pubmed24n0620.xml 
035 |a (DE-627)NLM186025149 
035 |a (NLM)19173350 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Vasu Dev, R  |e verfasserin  |4 aut 
245 1 0 |a Identification of degradation products in stressed tablets of Rabeprazole sodium by HPLC-hyphenated techniques 
264 1 |c 2009 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 07.05.2009 
500 |a Date Revised 21.11.2013 
500 |a published: Print 
500 |a Citation Status MEDLINE 
520 |a Copyright (c) 2009 John Wiley & Sons, Ltd. 
520 |a Three unknown impurities of Rabeprazole, a proton pump inhibitor, were formed in the formulated drug under the stress conditions, [40 degrees C/75% relative humidity (RH) for 6 months] with relative retention times (RRTs) 0.17, 0.22 and 0.28. The Impurity-I (0.17 RRT) was isolated using preparative HPLC and characterized by NMR and MS. The other two impurities, Impurity-II (RRT 0.22) and Impurity-III (RRT 0.28) could not be isolated, hence they are characterized by HPLC-hyphenated techniques, LC-NMR and high-resolution LC-MS. On the basis of the spectral data, the Impurity-I, Impurity-II and Impurity-III were characterized as 1-(1H-benzo[d]imidazol-2-yl)-3-methyl-4-oxo-1,4-dihydropyridine-2-carboxylic acid, 1H-benzo [d] imidazole-2-sulfonic acid and 4-(3-methoxy propoxy)-3-methyl-2-pyridine carboxylic acid, respectively 
650 4 |a Journal Article 
650 7 |a 2-Pyridinylmethylsulfinylbenzimidazoles  |2 NLM 
650 7 |a Anti-Ulcer Agents  |2 NLM 
650 7 |a Tablets  |2 NLM 
650 7 |a Rabeprazole  |2 NLM 
650 7 |a 32828355LL  |2 NLM 
700 1 |a Sai Uday Kiran, G  |e verfasserin  |4 aut 
700 1 |a Venkata Subbaiah, B  |e verfasserin  |4 aut 
700 1 |a Suresh Babu, B  |e verfasserin  |4 aut 
700 1 |a Moses Babu, J  |e verfasserin  |4 aut 
700 1 |a Dubey, P K  |e verfasserin  |4 aut 
700 1 |a Vyas, K  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Magnetic resonance in chemistry : MRC  |d 1985  |g 47(2009), 5 vom: 01. Mai, Seite 443-8  |w (DE-627)NLM098179667  |x 1097-458X  |7 nnns 
773 1 8 |g volume:47  |g year:2009  |g number:5  |g day:01  |g month:05  |g pages:443-8 
856 4 0 |u http://dx.doi.org/10.1002/mrc.2404  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 47  |j 2009  |e 5  |b 01  |c 05  |h 443-8